Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000095

Type of data
NGS (WGS, Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
9.8 TB
File formats
  • FASTQ
  • BAM
Research
hum0094
Date published
2020-09-28
Date modified
2026-09-26
DDBJ Search
JGAD000095 (opens in a new tab)
JGA Study
JGAS000095 (opens in a new tab)

Analysis method

WGS

Materials and participants
Triple negative breast cancer (ICD10: C50): 16 cases
  • Health status
    Affected
  • Subject count
    16 (Individual)
Disease
Triple negative breast cancer (C50)
Sample description
DNAs extracted from tumor tissues and paired non-tumor tissues or peripheral blood cells as non-tumor tissues
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
NEBNext Ultra DNA Library Prep Kit for Illumina
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Read type
Paired-end
Read length
103 bp
Reference genome
GRCh37
Phenotype data
Included
Data use policy
NBDC data sharing policy (JGAP000001)

WES

Materials and participants
Triple negative breast cancer (ICD10: C50): 36 cases
  • Health status
    Mixed
  • Subject count
    36 (Individual)
Disease
Triple negative breast cancer (C50)
Sample description
DNAs extracted from tumor tissues and paired non-tumor tissues or peripheral blood cells as non-tumor tissues
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
NEBNext Ultra DNA Library Prep Kit for Illumina
SureSelect Human All Exon V5
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Illumina NovaSeq 6000
Read type
Paired-end
Read length
Breast cancer: 103 bp
Reference genome
GRCh37
GRCh38
Phenotype data
Included
Data use policy
NBDC data sharing policy (JGAP000001)
No use by private-sector companies (JGAP000003)

RNA-seq

Materials and participants
Triple negative breast cancer (ICD10: C50): 23 cases (including 2 cases for JGAD000457)
Estrogen receptor-positive breast cancer (ICD10: C50): 17 cases
HER2-positive breast cancer (ICD10: C50): 15 cases
  • Health status
    Affected
  • Subject count
    55 (Individual)
Disease
Triple negative breast cancer (C50)
Estrogen receptor-positive breast cancer (C50)
HER2-positive breast cancer (C50)
Sample description
RNAs extracted from tumor tissues
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext Ultra Directional RNA Library Prep Kit for Illumina
TruSeq RNA Exome
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2000
Illumina HiSeq 2500
Read type
Paired-end
Read length
Breast cancer: 103 bp
Data use policy
NBDC data sharing policy (JGAP000001)
No use by private-sector companies (JGAP000003)